Phase 1 Study Of Ziprasidone Pharmacokinetics Of Reduced Food Effect Formulation B16 Under Fed And Fasting Conditions Compared To Commercial Geodon Capsules Under Fed Conditions In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2011
At a glance
- Drugs Ziprasidone (Primary)
- Indications Anxiety disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 19 Mar 2009 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 19 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 19 Mar 2009 Actual initiation date changed from Feb 2009 to Jan 2009 as reported by ClinicalTrials.gov.